Patent · US Active

Methods of diagnosing Parkinson's disease by measuring expression level of RNA encoding human protein HLLRCR-1

US7348149B2 · kind B2 · utility

3Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 28, 2006
Grant dateMar 25, 2008
Priority date
Expiry dateSep 19, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides novel polynucleotides encoding HLLRCR-1 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel HLLRCR-1 polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly nervous system diseases and/or disorders. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.